KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Non Operating Income: 2018

  • Aurinia Pharmaceuticals' Non Operating Income was N/A to $1.3 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$25,000, marking a year-over-year change of. This contributed to the annual value of -$39,000 for FY2019, which is N/A change from last year.
  • According to the latest figures from Q4 2018, Aurinia Pharmaceuticals' Non Operating Income is $1.3 million, which was up 336.06% from -$563,000 recorded in Q3 2018.
  • In the past 5 years, Aurinia Pharmaceuticals' Non Operating Income registered a high of $1.3 million during Q4 2018, and its lowest value of -$1.7 million during Q3 2014.
  • Moreover, its 1-year median value for Non Operating Income was $383,000 (2018), whereas its average is $383,000.